Update README.md

README.md

@@ -1,22 +1,52 @@
 ---
-base_model: unsloth/Llama-3.2-1B
+base_model: meta-llama/Llama-3.2-1B
 language:
 - en
+- hi
 license: apache-2.0
 tags:
 - text-generation-inference
 - transformers
+- torch
+- trl
 - unsloth
 - llama
 - gguf
+datasets:
+- student-abdullah/BigPharma_Generic_Q-A_Format_Augemented_Hinglish_Dataset
 ---
 
-# Uploaded  model
+
+# Uploaded model
 
 - **Developed by:** student-abdullah
 - **License:** apache-2.0
-- **Finetuned from model :** unsloth/Llama-3.2-1B
-
-This llama model was trained 2x faster with [Unsloth](https://github.com/unslothai/unsloth) and Huggingface's TRL library.
+- **Finetuned from model:** meta-llama/Llama-3.2-1B
+- **Created on:** 30th September, 2024
 
+---
+# Acknowledgement
 [<img src="https://raw.githubusercontent.com/unslothai/unsloth/main/images/unsloth%20made%20with%20love.png" width="200"/>](https://github.com/unslothai/unsloth)
+
+---
+# Model Description
+This model is fine-tuned from the meta-llama/Llama-3.2-1B base model to enhance its capabilities in generating relevant and accurate responses related to generic medications under the PMBJP scheme. The fine-tuning process included the following hyperparameters:
+
+- Fine Tuning Template: Llama 3.1 Q&A
+- Max Tokens: 512
+- LoRA Alpha: 10
+- LoRA Rank (r): 128
+- Learning rate: 1e-4
+- Gradient Accumulation Steps: 2
+- Batch Size: 4
+- Qunatization: No Quantisation
+
+---
+# Model Quantitative Performace
+- Training Quantitative Loss: 0.1167 (at final 5,200th epoch)
+
+---
+# Limitations
+- Token Limitations: With a max token limit of 512, the model might not handle very long queries or contexts effectively.
+- Training Data Limitations: The model’s performance is contingent on the quality and coverage of the fine-tuning dataset, which may affect its generalizability to different contexts or medications not covered in the dataset.
+- Potential Biases: As with any model fine-tuned on specific data, there may be biases based on the dataset used for training.